Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
10,637,831
-
Shares change
-
+39,630
-
Total reported value, excl. options
-
$127,760,820
-
Value change
-
+$781,532
-
Number of buys
-
29
-
Number of sells
-
17
-
Price
-
$12.01
Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q3 2016
As of 30 Sep 2016 Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) had 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,637,831 shares of stock of the company.
Largest 10 holders included FMR LLC, BROOKSIDE CAPITAL MANAGEMENT LLC, Partner Fund Management, L.P., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, BlackRock Fund Advisors, EVENTIDE ASSET MANAGEMENT, LLC, Casdin Capital, LLC, DEERFIELD MANAGEMENT CO, and JPMORGAN CHASE & CO.
This table shows 50 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.